219 related articles for article (PubMed ID: 28181629)
1. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.
Clague F; Mercer SW; McLean G; Reynish E; Guthrie B
Age Ageing; 2017 Jan; 46(1):33-39. PubMed ID: 28181629
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.
Kristensen RU; Nørgaard A; Jensen-Dahm C; Gasse C; Wimberley T; Waldemar G
J Alzheimers Dis; 2018; 63(1):383-394. PubMed ID: 29578483
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.
Baron-Franco B; McLean G; Mair FS; Roger VL; Guthrie B; Mercer SW
Br J Gen Pract; 2017 May; 67(658):e314-e320. PubMed ID: 28396366
[TBL] [Abstract][Full Text] [Related]
4. Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.
Barry HE; Cooper JA; Ryan C; Passmore AP; Robinson AL; Molloy GJ; Darcy CM; Buchanan H; Hughes CM
J Alzheimers Dis; 2016 Apr; 52(4):1503-13. PubMed ID: 27079714
[TBL] [Abstract][Full Text] [Related]
5. Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan.
Lai SW; Lin CH; Liao KF; Su LT; Sung FC; Lin CC
Geriatr Gerontol Int; 2012 Jul; 12(3):491-8. PubMed ID: 22233227
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity profile of dementia patients in primary care: are they sicker?
Schubert CC; Boustani M; Callahan CM; Perkins AJ; Carney CP; Fox C; Unverzagt F; Hui S; Hendrie HC
J Am Geriatr Soc; 2006 Jan; 54(1):104-9. PubMed ID: 16420205
[TBL] [Abstract][Full Text] [Related]
7. Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.
Freund J; Meiman J; Kraus C
J Prim Care Community Health; 2013 Oct; 4(4):286-93. PubMed ID: 24327665
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
9. Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.
McLean G; Hindle JV; Guthrie B; Mercer SW
BMC Neurol; 2017 Jul; 17(1):126. PubMed ID: 28666413
[TBL] [Abstract][Full Text] [Related]
10. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.
Walsh KA; O'Regan NA; Byrne S; Browne J; Meagher DJ; Timmons S
Int Psychogeriatr; 2016 Nov; 28(11):1807-1820. PubMed ID: 27527842
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge.
Hudhra K; García-Caballos M; Casado-Fernandez E; Jucja B; Shabani D; Bueno-Cavanillas A
J Eval Clin Pract; 2016 Apr; 22(2):189-93. PubMed ID: 26399173
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.
Zhu L; Rochon PA; Gruneir A; Wu W; Giannakeas V; Austin PC; Stall NM; McCarthy L; Alberga A; Herrmann N; Gill SS; Bronskill SE
Drugs Aging; 2019 Sep; 36(9):875-884. PubMed ID: 31309528
[TBL] [Abstract][Full Text] [Related]
13. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Hoffmann F; van den Bussche H; Wiese B; Schön G; Koller D; Eisele M; Glaeske G; Scherer M; Kaduszkiewicz H
BMC Psychiatry; 2011 Dec; 11():190. PubMed ID: 22145796
[TBL] [Abstract][Full Text] [Related]
14. Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.
Silay K; Yalcin A; Akinci S; Gursoy FG; Sener Dede D
Wien Klin Wochenschr; 2017 Nov; 129(21-22):799-804. PubMed ID: 28864869
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.
Haider SI; Johnell K; Thorslund M; Fastbom J
Clin Ther; 2008 Feb; 30(2):419-27. PubMed ID: 18343279
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with appropriate knowledge of the indications for prescribed drugs among community-dwelling older patients with polypharmacy.
Bosch-Lenders D; Maessen DW; Stoffers HE; Knottnerus JA; Winkens B; van den Akker M
Age Ageing; 2016 May; 45(3):402-8. PubMed ID: 27013501
[TBL] [Abstract][Full Text] [Related]
17. Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care.
Smith DJ; Court H; McLean G; Martin D; Langan Martin J; Guthrie B; Gunn J; Mercer SW
J Clin Psychiatry; 2014 Nov; 75(11):1202-8; quiz 1208. PubMed ID: 25470083
[TBL] [Abstract][Full Text] [Related]
18. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
Haider SI; Johnell K; Weitoft GR; Thorslund M; Fastbom J
J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
[TBL] [Abstract][Full Text] [Related]
19. Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: a nationwide database study.
Lin SK; Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2015 Feb; 161():108-15. PubMed ID: 25527314
[TBL] [Abstract][Full Text] [Related]
20. Changes in the Prevalence of Polypharmacy in People with and without Dementia from 2000 to 2014: A Nationwide Study.
Kristensen RU; Nørgaard A; Jensen-Dahm C; Gasse C; Wimberley T; Waldemar G
J Alzheimers Dis; 2019; 67(3):949-960. PubMed ID: 30689562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
